These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Neurodevelopmental disorders. New hope for a devastating neurological disorder. Miller G Science; 2011 Dec; 334(6063):1615. PubMed ID: 22194537 [No Abstract] [Full Text] [Related]
13. Novel human pathological mutations. Gene symbol: UBE3A. Disease: Angelman Syndrome. Tzagkaraki E; Christalena S; Helen F; Argyris D; Ariadni M; Emmanuel K Hum Genet; 2009 Aug; 126(2):331. PubMed ID: 19693993 [No Abstract] [Full Text] [Related]
14. [Angelman syndrome--diagnosis and therapy of genomic imprinting disorders]. Saito S No To Hattatsu; 2009 May; 41(3):208-13. PubMed ID: 19517792 [No Abstract] [Full Text] [Related]
15. Angelman syndrome due to a termination codon mutation of the UBE3A gene. Al-Maawali A; Machado J; Fang P; Dupuis L; Faghfoury H; Mendoza-Londono R J Child Neurol; 2013 Mar; 28(3):392-5. PubMed ID: 22566713 [TBL] [Abstract][Full Text] [Related]
16. Neurodevelopmental outcome in Angelman syndrome: genotype-phenotype correlations. Mertz LG; Thaulov P; Trillingsgaard A; Christensen R; Vogel I; Hertz JM; Ostergaard JR Res Dev Disabil; 2014 Jul; 35(7):1742-7. PubMed ID: 24656292 [TBL] [Abstract][Full Text] [Related]
17. A novel missense mutation of the ubiquitin protein ligase E3A gene in a patient with Angelman syndrome. Bai JL; Qu YJ; Zou LP; Yang XY; Liu LJ; Song F Chin Med J (Engl); 2011 Jan; 124(1):84-8. PubMed ID: 21362313 [TBL] [Abstract][Full Text] [Related]
19. Unraveling the mechanisms of Angelman Syndrome. Narasimhan K Nat Neurosci; 2007 Mar; 10(3):275. PubMed ID: 17318219 [No Abstract] [Full Text] [Related]
20. Atypical absences and recurrent absence status in an adult with Angelman syndrome due to the UBE3A mutation. Espay AJ; Andrade DM; Wennberg RA; Lang AE Epileptic Disord; 2005 Sep; 7(3):227-30. PubMed ID: 16162432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]